首页> 外文OA文献 >Phase 3 efficacy results of a single dose of NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients

【2h】

Phase 3 efficacy results of a single dose of NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients

机译：单剂量NEPA的疗效结果，Netupitant和Palonosetron的固定组合，与用于预防中国患者的化疗诱导的化疗诱导的恶心和呕吐（CINV）的3天的3天

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
L. Zhang; S. Lu; A. Dechaphunkul; S. Chessari; C. Lanzarotti; K. Jordan; M. Aapro;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [J] . LZhang, SLu, JFeng, Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第2期

机译：评估单剂量NEPA，Netupitant和Palonosetron的固定止吐组合的功效的随机期III研究与预防高均匀化疗（HEC）的患者预防化疗诱导的化疗诱导的恶心和呕吐（CINV）的试剂
2. Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study [J] . Jianhua Chang, Gongyan Chen, Dong Wang, Cancer Medicine . 2020,第14期

机译：Nepa的疗效，Netupitant和Palonosetron的固定止吐组合，与在随机相3研究中接受高均匀化疗（HEC）的中国患者中预防化疗诱导的恶性和呕吐（CINV）的3天的抑制剂方案
3. Improving the functional status of patients with cancer by more effectively preventing chemotherapy-induced nausea and vomiting (CINV): results of a phase 3 study of NEPA (fixed-dose combination of netupitant and palonosetron) [J] . European journal of oncology nursing: the official journal of European Oncology Nursing Society . 2014,第Suppla1期

机译：通过更有效地预防化学疗法引起的恶心和呕吐（CINV）改善癌症患者的功能状态：NEPA（固定剂量的netupitant和palonosetron组合使用）的三期研究结果
4. A randomized phase III study evaluating the efficacy of single-dose NEPA a fixed antiemetic combination of netupitant and palonosetron versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [O] . L Zhang, S Lu, J Feng, -1

机译：一项III期随机研究评估单剂量NEPAnetupitant和palonosetron的固定止吐药与预防性方案在接受高促发性化疗（HEC）的患者中预防化疗引起的恶心和呕吐（CINV）的疗效
5. Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study [O] . Jianhua Chang, Gongyan Chen, Dong Wang, 2020

机译：Nepa的疗效，Netupitant和Palonosetron的固定止吐组合，与在随机相3研究中接受高均匀化疗（HEC）的中国患者中预防化疗诱导的恶性和呕吐（CINV）的3天的抑制剂方案

Phase 3 efficacy results of a single dose of NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients

著录项

引文网络

相似文献

相关主题

期刊订阅